alexa Investigation Of The Antitumor Activity Of Cisplatin Loaded Long-circulating And PH-sensitive Liposomes In A Breast Cancer Animal Model | 15923
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd World Congress on Cancer Science & Therapy

Oliveira M. C, Franco M. S, Teixeira C. S, Silveira J. N and De barros A. L. B
Posters: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.029
Abstract
Recent experimental data suggest that cisplatin (CDDP) may have an important role on triple negative breast cancer (TNBC) treatment. Besides the great antitumor efficacy of this anticancer agent, severe side effects and the possibility of resistance development limit the therapy. Previous studies of our research group have shown that the encapsulation of CDDP into long- circulating and pH-sensitive liposomes (SpHL-CDDP) was able to overcome cell resistance, reduce acute toxicity and enhance antitumor efficacy on Ehrlich tumor-bearing mice. Therefore, the purpose of this work was to develop a TNBC xenograft animal model, and evaluate the antitumor activity after SpHL-CDDP administration . Firstly, Balb/c nude mice were inoculated with MDA-MB-231 cell line and the animals were divided into three groups when the tumor reached approximately 50mm?. The animals were treated, intravenously, once a week for three weeks with 0.9% (w/v) saline, free CDDP (cumulative dose equal to 30mg/kg) or SpHL-CDDP (cumulative dose equal to 12mg/kg). Tumor volume was monitored twice a week using a caliper. Body weight of all animals was also monitored at the same time frame. Control group presented an increase of the tumor volume (573%) during the entire experimental time. This increase was statistically higher from that observed for treated groups. No statistically difference on tumor growth was observed when treated groups (free CDDP or SpHL-CDDP) were compared. However, animals treated with free CDDP were the only ones to present loss of weight (~13%) at the end of the experiment, while animals treated with SpHL-CDDP or 0.9% (w/v) saline presented a slight gain of weight (~2%). Results indicate that higher concentration of free CDDP is needed to reach the antitumor efficacy attained after SpHL-CDDP treatment. In addition, animals of the free CDDP treated group showed loss of weight indicating the appearance of toxicity. These findings demonstrate that the encapsulation allows administration of lower concentration of the drug leading to the same antitumor efficacy together with lesser side effects. In summary, these results suggest that SpHL-CDDP may be useful on TNBC treatmen
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7